Clinical Trials Browser

Phase 2 × Urologic Neoplasms × Drug Therapy × Clear all

NCT06427057 2024-05-23

A Study of Cadonilimab（AK104）Combined With Standard Treatment for Function Preservation in Urinary System Tumors

Phase 2 Not yet recruiting

Urologic Neoplasms